Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IIa trial of ICT 140 in patients with ovarian cancer at high risk of first recurrence

Next Previous
X
Search
Trial Profile

Phase IIa trial of ICT 140 in patients with ovarian cancer at high risk of first recurrence

Status: Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ICT 140 (Primary)
  • Indications Ovarian cancer
  • Focus Therapeutic Use

    • Most Recent Events

    • 17 Sep 2014 Planned number of patients changed from 60 to 56, as reported in an ImmunoCellular Therapeutics media release.
    • 13 Jan 2014 Enrolment is expected to begin in the third quarter of 2014, according to an ImmunoCellular Therapeutics media release.
    • 08 Aug 2013 Protocol was enhanced to include a larger patient population and a comparator group, according to an ImmunoCellular Therapeutics media release; the study will be at approximately 4 clinical sites.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top